FTC-PR-240206-1 (Feb. 6, 2024)
FTC Submits Comment on March-In Rights to Promote Efforts to Lower Drug Prices – Comment submitted to NIST supports the use of march-in rights as a check on inflated pharmaceutical prices
Today the Federal Trade Commission issued a comment (PDF) in response to the National Institute of Standards and Technology’s (NIST) request for information on its Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights under the Bayh-Dole Act.
Date: Feb. 6, 2024
Accessed: Sep. 10, 2024
Categories:
PDF Notes:
- The PDF viewer below disables the links inside the PDF file.
- The PDF file may be downloaded if you wish.
- All links within the PDF Download are fully functional.